ALEXANDER SENG: Open Payments
NPI 1891340048 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 25 payments from 19 companies in 2025. Trend: 2023 $5,094 · 2024 $3,190 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $267 |
| AstraZeneca Pharmaceuticals LP | 2 | $207 |
| JAZZ PHARMACEUTICALS INC. | 1 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $127 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Verona Pharma, Inc. | 1 | $125 |
| Dexcom, Inc. | 1 | $116 |
| Insulet Corporation | 1 | $113 |
| Amgen Inc. | 1 | $101 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
Products named: DUPIXENT, BREZTRI, XYWAV, LUMRYZ, Ohtuvayre, DEXCOM G7 GSS (161), OMNIPOD, ACTHAR.
Industry payments across PA — which companies pay providers there.
